Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-431-5 | CAS number: 470-82-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- Between 27 March and 17 April 1991.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- To address toxicological endpoints as part of the REACH registration of Cineole (Target Substance) it is proposed to read-across to Clarycet (Source Substance). The use of read-across works within the spirit of REACH and the stated aim of the legislation to reduce animal testing where possible. The Target Substance and Source Substance have been characterised in using the categories and databases present in the OECD (Q)SAR Toolbox. From the profile, it can be seen that the two substances share structural similarities and also "mechanistic action" similarities which are both general and endpoint specific. Therefore read-across is justified.
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Clarycet
- IUPAC Name:
- Clarycet
- Reference substance name:
- 131766-73-9
- EC Number:
- 603-508-6
- Cas Number:
- 131766-73-9
- IUPAC Name:
- 131766-73-9
- Reference substance name:
- Tetrahydro-4-methyl-2-propyl-2H-pyran-4-yl acetate
- IUPAC Name:
- Tetrahydro-4-methyl-2-propyl-2H-pyran-4-yl acetate
- Details on test material:
- - Name of test material (as cited in study report): Tetrahydro-4-methyl-2-propyl-2H-pyran-4-yl acetate (Clarycet)
- Analytical purity: > 94 %
- Lot/batch No.: 6370
- Storage condition of test material: At room temperature in the dark.
- Physical state: Clear colourless liquid.
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd, Margate, Kent, England.
- Age at study initiation: 4 to 6 weeks
- Weight at study initiation: 108 - 152 g
- Fasting period before study: Overnight prior to dosing and approximately 4 h after dosing.
- Housing: In groups of up to five rats by sex in metal cages with wire mesh floors.
- Diet (e.g. ad libitum): standard rodent diet (Biosure LAD 1) ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: Seven days prior to the start.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21- 23 °C
- Humidity (%): mean of 57 %
- Air changes (per hr): Approximately 15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light/dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
Not applicable
MAXIMUM DOSE VOLUME APPLIED: 8.16 mL/kg (specific gravity 0.98) - Doses:
- Preliminary study: 2.5 g/kg bw
Main study: 3.2, 5.0, 8.0 g/kg - No. of animals per sex per dose:
- Preliminary study: 2/sex/dose
Main study: 5/sex/dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration:
Preliminary study: 5 days
Main study: 14 days
- Frequency of observations and weighing: Rats were observed soon after dosing and at frequent intervals on Day 1 (day of dosing - minimum period of 5 hours) and twice daily thereafter, once in teh morning and again at the end of the experimental day. Clinical signs were recorded at each observation.
- Necropsy of survivors performed: yes. All surviving animals on the main study were killed on Day 15 and the abdominal and thoracic cavities examined.
- Other examinations performed: Approximate time of death of individual rats, the nature, severity, approximate time of onset and duration of each toxic sign; individual bodywieghts of rats of Days 1 (day of dosing), 8 and 15 or at death. - Statistics:
- The acute median lethal oral dose to male and female rats was caluclated using the method of Finney (1871, Probit Analysis). Separate LD50 values for males and females were estimated by undertaking probit analysis on the mortality data from the main study by fittingtwo parallel lines to teh data (males only and females onle) using the technique described by Finney (1978). A chi-square test was carried out to cehcl that the data did not cotnain any evidence on non-parallelism.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4.5 other: g/kg
- Based on:
- test mat.
- 95% CL:
- 3.3 - 5.8
- Remarks on result:
- other: The slope of the probit line was 5.6 with a standard error of 1.87 using long transforation of dose.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4.7 other: g/kg
- Based on:
- test mat.
- 95% CL:
- 3.2
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 4.3 other: g/kg
- 95% CL:
- 2.8 - 6.1
- Mortality:
- There were deaths following a single oral dose of the test substance among male and female rats dosed at 3.2 g/lg bw and above. Deaths occurred at intervals from within 5 hours of treatment until Day 4. Among decedencents, slight bodyweight gains were recorded for two males and one female dosed at 8.0 g/kg; bodyweight losses were recorded for remainin rats. Post mortem examination of rats that died during the study revealed no macroscopic abnormalities.
- Clinical signs:
- other: Pilo-erection and abnormal body carriage (hunched posture) were observed in all rats within 5 minutes of dosing and were accompanied at this time by increased salivation in rats dosed at 5.0 g/kg plus abnormal gait (waddlig) and lethargy in rats treated a
- Gross pathology:
- Terminal autopsy revealed no macroscopic abnormalities.
- Other findings:
- Preliminary study: The results of the preliminary study indicated that the acute median lethal oral dose to male and female rats to Clarycet was greater than 2.5 g/kg bodyweight.
The difference between the lines for male and female rats was not statistically significant. Teh chi-square test for parallelism gave no evidence of non-parallelism.
Any other information on results incl. tables
Number of deaths of rats dosed orally with Clarycet
Sex |
Dose (g/kg) |
No. of deaths per group |
Male |
3.2 |
1 |
5.0 |
2 |
|
8.0 |
5 |
|
Female |
3.2 |
2 |
5.0 |
2 |
|
8.0 |
5 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test substance was assessed for acute oral toxicity in the rat according to OECD guideline 401. The acute median lethal oral dose and the 95 % confidence limit for males and females combined were 4.5 g/kg body weight (3.3 - 5.8 g/kg confidence limits); for males only it was estimated to be 4.7 g/kg body weight (3.2 - 7.0 g/kg confidence limits) and for females only was 4.3 g/kg body weight (2.8 - 6.1 g/kg confidence limits).
To address toxicological endpoints as part of the REACH registration of Cineole (Target Substance) it is proposed to read-across to Clarycet (Source Substance).
The use of read-across works within the spirit of REACH and the stated aim of the legislation to reduce animal testing where possible.
The Target Substance and Source Substance have been characterised in using the categories and databases present in the OECD (Q)SAR Toolbox. From the profile, it can be seen that the two substances share structural similarities and also "mechanistic action" similarities which are both general and endpoint specific.
Therefore read-across is justified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.